DOI: 10.3390/jfb17080380 ISSN: 2079-4983

Heterologous Fibrin Biopolymer for Post-Extraction Alveolar Bone Healing in Streptozotocin-Induced Diabetic Rats

Suelen Paini, Tania Mary Cestari, Ana Carolina Cestari Bighetti, Rafael Carneiro Ortiz, Rui Seabra Ferreira, Benedito Barraviera, Nathália Dantas Duarte, Rogerio Leone Buchaim, Evelyn Lorene Rodrigues da Silva, Bruna Trazzi Pagani, Gustavo Pompermaier Garlet, Gerson Francisco de Assis, Daniela Vieira Buchaim

Type 1 diabetes mellitus (DM1) is characterized by autoimmune destruction of pancreatic β-cells, resulting in insulin deficiency and persistent hyperglycemia, which impair bone metabolism and compromise post-extraction alveolar bone healing. Heterologous fibrin biopolymer (HFB) has previously demonstrated biocompatibility, biodegradability, bioactivity, and osteoconductive properties under normoglycemic conditions. Therefore, the study investigated the association of HFB with post-extraction alveolar bone healing in streptozotocin-induced diabetic rats, using the diabetic blood clot as a biological control. Forty-eight adult male Wistar rats were induced to DM1 by a single intraperitoneal injection of streptozotocin (52 mg/kg). Animals were included after confirmation of hyperglycemia (fasting blood glucose ≥ 250 mg/dL) measured seven days after STZ administration: blood clot (BCG; n = 24) or HFB (HFBG; n = 24). Seven days after DM1 induction, the right maxillary incisor was extracted, and the sockets were filled according to group allocation. Animals were euthanized at 7, 14, and 42 days post-extraction. Fasting blood glucose levels were monitored, and pancreatic insulin immunohistochemistry was performed to characterize the diabetic condition. Alveolar bone healing was assessed by micro-CT, histological (HE), histomorphometric, and picrosirius red analyses. The diabetic phenotype was confirmed by persistent fasting hyperglycemia (260–589 mg/dL) and reduced pancreatic insulin immunostaining in β-cells. At 42 days, bone volume (BV) was 31.86% higher in the HFBG than in the BCG (p < 0.05). BCG exhibited higher trabecular number (Tb.N), while HFBG exhibited higher trabecular thickness (Tb.Th) (p < 0.05). Histologically, the HFBG shows a more mature, compact, and organized bone structure, whereas the BCG presents bone tissue with a more trabecular and immature architecture. HFBG showed the lowest percentage of thin fibers at the late stage, whereas BCG maintained similar values from 14 to 42 days (p < 0.05). These findings suggest that HFB was associated with favorable changes in selected late-stage parameters of post-extraction alveolar bone healing in an STZ-induced diabetic model.

More from our Archive